SCHEMBL26192887

SCHEMBL26192887

O=[N+]([O-])c1ccc(-c2ccc(Cl)cc2)cc1-c1ccn(Cc2cccnc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.46
▸ MAPT P10636 3/20 0.42
▸ HTT P42858 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MARS1 P56192 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ PSD A5PKW4 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25378904 0.92 CYP11B1 (0.48) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL30510003 0.92 CYP11B1 (0.48) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL30509946 0.90 GRIN1 (0.43) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL25380258 0.90 GRIN1 (0.43) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL26192893 0.90 MAPT (0.42) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL30510183 0.85 POLB (0.41) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL25379857 0.85 POLB (0.41) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL25257139 0.84 HTT (0.44) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL30509940 0.84 HTT (0.44) POLBMAPTHTTSMN1; SMN2KDM4E
SCHEMBL26192886 0.83 MARS1 (0.41) HTTSMN1; SMN2KDM4ERAB9AMARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 — — US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 POLB 1804/4885MAPT 2994/4885HTT 3826/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 POLB 1804/4885MAPT 2994/4885HTT 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback